| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.763 | 0.003 | 0.783 | Anesthetic local | 0.694 0.003 DBMET03532 0.721 0.003 DBMET03533 0.783 0.003 DBMET00269 0.367 0.008 DBMET01742 0.308 0.012 DBMET03534 0.387 0.007 DBMET03535 | DBMET00269 | |
| 0.546 | 0.014 | 0.633 | Calcium channel L-type activator | 0.547 0.014 DBMET03532 0.56 0.011 DBMET03533 0.529 0.018 DBMET00269 0.633 0.004 DBMET01742 0.625 0.004 DBMET03534 0.609 0.005 DBMET03535 | DBMET01742 | |
| 0.336 | 0.014 | 0.336 | Gastrin inhibitor | 0.296 0.036 DBMET03532 0.299 0.033 DBMET03533 0.28 0.049 DBMET00269 0.297 0.035 DBMET01742 0.251 0.078 DBMET03534 0.232 0.102 DBMET03535 | ||
| 0.332 | 0.012 | 0.332 | Nav1.2 sodium channel blocker | 0.233 0.025 DBMET03532 0.212 0.03 DBMET03533 0.19 0.038 DBMET00269 0.186 0.04 DBMET01742 0.124 0.078 DBMET03534 | ||
| 0.406 | 0.096 | 0.46 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.46 0.055 DBMET01742 0.318 0.189 DBMET03534 0.312 0.197 DBMET03535 | DBMET01742 | |
| 0.312 | 0.008 | 0.312 | Nav1.3 sodium channel blocker | 0.216 0.02 DBMET03532 0.292 0.009 DBMET03533 0.173 0.035 DBMET00269 0.311 0.008 DBMET01742 0.216 0.02 DBMET03534 0.172 0.035 DBMET03535 | ||
| 0.391 | 0.116 | 0.471 | Caspase 9 stimulant | 0.471 0.072 DBMET03532 0.419 0.1 DBMET03533 0.359 0.138 DBMET00269 0.332 0.161 DBMET01742 0.411 0.104 DBMET03534 0.304 0.189 DBMET03535 | DBMET03532 | |
| 0.304 | 0.032 | 0.336 | Anesthetic general | 0.336 0.026 DBMET03532 0.272 0.041 DBMET03533 0.282 0.038 DBMET00269 0.2 0.074 DBMET01742 0.225 0.062 DBMET03534 0.181 0.086 DBMET03535 | DBMET03532 | |
| 0.311 | 0.04 | 0.34 | Psychostimulant | 0.315 0.039 DBMET03532 0.25 0.058 DBMET03533 0.188 0.087 DBMET00269 0.336 0.034 DBMET01742 0.34 0.033 DBMET03534 0.206 0.076 DBMET03535 | DBMET03534 | |
| 0.295 | 0.036 | 0.388 | Tyrosine 3 hydroxylase inhibitor | 0.368 0.012 DBMET03532 0.237 0.081 DBMET03533 0.303 0.032 DBMET00269 0.311 0.028 DBMET01742 0.388 0.009 DBMET03534 0.32 0.025 DBMET03535 | DBMET03534 | |
| 0.302 | 0.054 | 0.322 | Transcription factor STAT inhibitor | 0.322 0.044 DBMET03532 0.221 0.111 DBMET03533 0.31 0.05 DBMET00269 0.279 0.068 DBMET01742 0.299 0.056 DBMET03534 0.287 0.063 DBMET03535 | DBMET03532 | |
| 0.286 | 0.041 | 0.286 | Sigma receptor agonist | 0.266 0.045 DBMET03532 0.136 0.096 DBMET03533 0.186 0.067 DBMET00269 0.128 0.104 DBMET01742 0.13 0.103 DBMET03534 | ||
| 0.292 | 0.05 | 0.292 | Ca(v)3.3 blocker | 0.243 0.111 DBMET03532 0.223 0.147 DBMET03533 0.233 0.128 DBMET00269 0.238 0.119 DBMET01742 | ||
| 0.255 | 0.023 | 0.255 | Antipruritic | 0.249 0.025 DBMET03532 0.154 0.089 DBMET03533 0.183 0.062 DBMET00269 0.153 0.091 DBMET01742 0.148 0.097 DBMET03534 | ||
| 0.274 | 0.05 | 0.274 | 5 Hydroxytryptamine 1E antagonist | 0.253 0.071 DBMET03532 0.217 0.111 DBMET00269 0.271 0.053 DBMET01742 0.25 0.074 DBMET03534 0.214 0.115 DBMET03535 | ||
| 0.214 | 0.007 | 0.214 | Sphingosine 1-phosphate receptor 5 antagonist | 0.208 0.008 DBMET03532 0.189 0.017 DBMET03533 0.196 0.013 DBMET00269 0.194 0.014 DBMET01742 0.188 0.018 DBMET03534 0.177 0.027 DBMET03535 | ||
| 0.322 | 0.126 | 0.336 | Analgesic | 0.305 0.138 DBMET03532 0.231 0.201 DBMET03533 0.336 0.116 DBMET01742 0.314 0.131 DBMET03534 | DBMET01742 | |
| 0.267 | 0.071 | 0.288 | Transcription factor STAT3 inhibitor | 0.288 0.059 DBMET03532 0.211 0.12 DBMET03533 0.281 0.063 DBMET00269 0.253 0.081 DBMET01742 0.273 0.068 DBMET03534 0.266 0.072 DBMET03535 | DBMET03532 | |
| 0.2 | 0.008 | 0.202 | Sphingosine 1-phosphate receptor 2 antagonist | 0.202 0.007 DBMET03532 0.188 0.011 DBMET03533 0.181 0.014 DBMET00269 0.173 0.019 DBMET01742 0.174 0.018 DBMET03534 0.155 0.034 DBMET03535 | DBMET03532 | |
| 0.313 | 0.129 | 0.313 | Beta lactamase inhibitor | 0.213 0.177 DBMET01742 | ||
| 0.281 | 0.104 | 0.301 | Vasodilator, coronary | 0.301 0.087 DBMET03532 0.285 0.1 DBMET03533 0.242 0.143 DBMET00269 0.241 0.143 DBMET01742 0.264 0.12 DBMET03534 | DBMET03532 | |
| 0.195 | 0.019 | 0.195 | Falcipain 3 inhibitor | 0.173 0.027 DBMET03532 0.136 0.044 DBMET03533 0.173 0.027 DBMET00269 0.113 0.059 DBMET01742 0.089 0.083 DBMET03534 0.089 0.082 DBMET03535 | ||
| 0.25 | 0.082 | 0.25 | Cardiotonic | 0.213 0.108 DBMET03532 0.187 0.132 DBMET03533 0.239 0.09 DBMET00269 0.163 0.16 DBMET03535 | ||
| 0.19 | 0.023 | 0.19 | Nav1.6 sodium channel blocker | 0.167 0.038 DBMET03532 0.13 0.081 DBMET03533 0.127 0.085 DBMET00269 0.152 0.051 DBMET01742 0.131 0.079 DBMET03534 | ||
| 0.253 | 0.093 | 0.375 | Insulysin inhibitor | 0.265 0.083 DBMET03532 0.23 0.117 DBMET00269 0.367 0.029 DBMET01742 0.375 0.027 DBMET03534 0.351 0.034 DBMET03535 | DBMET03534 | |
| 0.174 | 0.017 | 0.205 | Sphingosine 1-phosphate receptor 4 antagonist | 0.156 0.028 DBMET03532 0.205 0.008 DBMET03533 0.145 0.038 DBMET00269 0.18 0.014 DBMET01742 0.161 0.024 DBMET03534 0.15 0.033 DBMET03535 | DBMET03533 | |
| 0.191 | 0.04 | 0.216 | Neurotensin receptor agonist | 0.216 0.028 DBMET03532 0.161 0.077 DBMET03533 0.188 0.042 DBMET00269 0.191 0.04 DBMET01742 0.216 0.028 DBMET03534 0.189 0.042 DBMET03535 | DBMET03534 | |
| 0.192 | 0.046 | 0.192 | Acetylcholine M1 receptor antagonist | 0.178 0.053 DBMET03532 0.139 0.086 DBMET03533 0.153 0.071 DBMET00269 0.121 0.107 DBMET01742 | ||
| 0.225 | 0.083 | 0.225 | Neuropeptide Y2 antagonist | 0.208 0.106 DBMET03532 0.174 0.173 DBMET00269 0.219 0.09 DBMET01742 0.203 0.115 DBMET03534 | ||
| 0.268 | 0.127 | 0.359 | Calcium channel activator | 0.252 0.144 DBMET03532 0.21 0.198 DBMET03533 0.224 0.179 DBMET00269 0.359 0.044 DBMET01742 0.346 0.052 DBMET03534 0.323 0.07 DBMET03535 | DBMET01742 | |
| 0.14 | 0.004 | 0.14 | CC chemokine 5 receptor agonist | 0.14 0.005 DBMET03532 0.097 0.025 DBMET03533 0.126 0.007 DBMET00269 0.097 0.026 DBMET01742 0.096 0.026 DBMET03534 0.087 0.044 DBMET03535 | ||
| 0.228 | 0.096 | 0.273 | Interleukin agonist | 0.235 0.09 DBMET03532 0.273 0.063 DBMET03533 0.21 0.112 DBMET00269 0.213 0.109 DBMET01742 0.221 0.102 DBMET03534 0.194 0.126 DBMET03535 | DBMET03533 | |
| 0.152 | 0.022 | 0.152 | Transcription factor STAT6 inhibitor | 0.15 0.023 DBMET03532 0.117 0.066 DBMET03533 0.147 0.026 DBMET00269 0.143 0.029 DBMET01742 0.141 0.031 DBMET03534 0.138 0.034 DBMET03535 | ||
| 0.15 | 0.022 | 0.194 | Prolactin inhibitor | 0.194 0.01 DBMET03532 0.143 0.025 DBMET03533 0.136 0.028 DBMET00269 0.105 0.051 DBMET01742 0.143 0.025 DBMET03534 0.093 0.063 DBMET03535 | DBMET03532 | |
| 0.203 | 0.08 | 0.203 | Anticonvulsant | 0.144 0.136 DBMET03533 0.198 0.084 DBMET01742 | ||
| 0.224 | 0.103 | 0.268 | Spasmolytic | 0.267 0.084 DBMET03532 0.213 0.11 DBMET03533 0.268 0.083 DBMET00269 0.22 0.105 DBMET01742 0.262 0.086 DBMET03534 0.264 0.085 DBMET03535 | DBMET00269 | |
| 0.218 | 0.099 | 0.403 | Superoxide dismutase inhibitor | 0.271 0.062 DBMET03532 0.239 0.082 DBMET00269 0.313 0.046 DBMET01742 0.403 0.026 DBMET03534 0.35 0.036 DBMET03535 | DBMET03534 | |
| 0.165 | 0.047 | 0.179 | Neurotrophic factor | 0.17 0.044 DBMET03532 0.159 0.051 DBMET03533 0.148 0.061 DBMET00269 0.174 0.041 DBMET01742 0.179 0.038 DBMET03534 0.152 0.057 DBMET03535 | DBMET03534 | |
| 0.13 | 0.013 | 0.187 | Nicotinic alpha4beta2 receptor antagonist | 0.105 0.027 DBMET03532 0.084 0.046 DBMET03533 0.075 0.056 DBMET00269 0.187 0.005 DBMET01742 0.149 0.008 DBMET03534 0.12 0.018 DBMET03535 | DBMET01742 | |
| 0.125 | 0.008 | 0.125 | Acetyl-CoA transferase inhibitor | 0.097 0.014 DBMET03532 0.099 0.014 DBMET03533 0.096 0.014 DBMET00269 0.115 0.01 DBMET01742 0.085 0.019 DBMET03534 0.085 0.019 DBMET03535 | ||
| 0.169 | 0.062 | 0.169 | Diuretic | 0.157 0.072 DBMET03532 0.119 0.106 DBMET00269 | ||
| 0.112 | 0.005 | 0.167 | Sphingosine kinase inhibitor | 0.131 0.004 DBMET03532 0.125 0.005 DBMET03533 0.114 0.005 DBMET00269 0.141 0.004 DBMET01742 0.167 0.004 DBMET03534 0.143 0.004 DBMET03535 | DBMET03534 | |
| 0.112 | 0.005 | 0.112 | Potassium channel (Tandem pore domain) blocker | 0.081 0.032 DBMET03532 0.079 0.038 DBMET03533 0.076 0.044 DBMET00269 0.091 0.016 DBMET01742 | ||
| 0.137 | 0.039 | 0.137 | Caspase 3 inhibitor | 0.134 0.042 DBMET03532 0.116 0.066 DBMET03533 0.136 0.039 DBMET00269 0.106 0.082 DBMET01742 0.102 0.089 DBMET03534 0.105 0.083 DBMET03535 | ||
| 0.113 | 0.015 | 0.135 | Sphingosine 1-phosphate receptor antagonist | 0.107 0.018 DBMET03532 0.135 0.009 DBMET03533 0.087 0.034 DBMET00269 0.087 0.035 DBMET01742 0.083 0.039 DBMET03534 | DBMET03533 | |
| 0.134 | 0.04 | 0.134 | Nav1.1 sodium channel blocker | 0.124 0.045 DBMET03532 0.103 0.062 DBMET03533 0.101 0.065 DBMET00269 | ||
| 0.151 | 0.064 | 0.158 | Neuropeptide Y1 antagonist | 0.148 0.069 DBMET03532 0.158 0.054 DBMET01742 0.155 0.058 DBMET03534 0.127 0.106 DBMET03535 | DBMET01742 | |
| 0.108 | 0.023 | 0.108 | Cannabinoid receptor agonist | |||
| 0.095 | 0.01 | 0.097 | Sphingosine 1-phosphate receptor 1 antagonist | 0.091 0.011 DBMET03532 0.097 0.01 DBMET03533 0.066 0.021 DBMET00269 0.063 0.024 DBMET01742 0.062 0.027 DBMET03534 0.052 0.049 DBMET03535 | DBMET03533 | |
| 0.129 | 0.045 | 0.155 | Nav1.4 sodium channel blocker | 0.136 0.04 DBMET03532 0.132 0.043 DBMET03533 0.121 0.051 DBMET00269 0.15 0.034 DBMET01742 0.155 0.032 DBMET03534 0.136 0.04 DBMET03535 | DBMET03534 | |
| 0.09 | 0.006 | 0.091 | Prolactin release inhibitor | 0.089 0.007 DBMET03532 0.091 0.006 DBMET03533 0.083 0.009 DBMET00269 0.06 0.054 DBMET01742 0.062 0.043 DBMET03534 | DBMET03533 | |
| 0.087 | 0.005 | 0.125 | Sphingosine kinase 1 inhibitor | 0.093 0.004 DBMET03532 0.104 0.004 DBMET03533 0.082 0.005 DBMET00269 0.119 0.004 DBMET01742 0.125 0.004 DBMET03534 0.113 0.004 DBMET03535 | DBMET03534 | |
| 0.138 | 0.06 | 0.138 | Cholinergic antagonist | 0.128 0.067 DBMET03532 0.104 0.09 DBMET03533 0.101 0.094 DBMET00269 0.116 0.077 DBMET01742 0.108 0.086 DBMET03534 | ||
| 0.135 | 0.059 | 0.135 | Acetylcholine antagonist | 0.125 0.066 DBMET03532 0.103 0.089 DBMET03533 0.1 0.093 DBMET00269 0.114 0.076 DBMET01742 0.106 0.084 DBMET03534 | ||
| 0.194 | 0.119 | 0.194 | Calpain inhibitor | 0.194 0.119 DBMET01742 | ||
| 0.235 | 0.162 | 0.264 | Immunosuppressant | 0.264 0.138 DBMET03532 0.237 0.159 DBMET03533 0.247 0.15 DBMET00269 | DBMET03532 | |
| 0.129 | 0.059 | 0.129 | Acetylcholine muscarinic antagonist | 0.123 0.064 DBMET03532 0.106 0.083 DBMET00269 | ||
| 0.195 | 0.126 | 0.263 | 5 Hydroxytryptamine release stimulant | 0.175 0.146 DBMET03532 0.263 0.083 DBMET01742 0.231 0.099 DBMET03534 0.179 0.142 DBMET03535 | DBMET01742 | |
| 0.082 | 0.014 | 0.092 | Sphingosine kinase 2 inhibitor | 0.091 0.01 DBMET03532 0.092 0.01 DBMET03533 0.071 0.021 DBMET00269 0.055 0.038 DBMET03534 | DBMET03533 | |
| 0.212 | 0.144 | 0.213 | Thyroid hormone beta antagonist | 0.213 0.144 DBMET03532 0.209 0.146 DBMET00269 | DBMET03532 | |
| 0.111 | 0.044 | 0.111 | Interleukin 1 beta converting enzyme inhibitor | 0.11 0.045 DBMET03532 0.093 0.067 DBMET03533 0.095 0.064 DBMET00269 | ||
| 0.08 | 0.013 | 0.097 | Nicotinic alpha3beta2 receptor antagonist | 0.059 0.027 DBMET03532 0.053 0.038 DBMET03533 0.097 0.008 DBMET01742 0.07 0.017 DBMET03534 0.056 0.032 DBMET03535 | DBMET01742 | |
| 0.103 | 0.037 | 0.132 | Acetylcholine nicotinic antagonist | 0.084 0.05 DBMET03532 0.073 0.063 DBMET03533 0.132 0.026 DBMET01742 0.108 0.035 DBMET03534 0.071 0.066 DBMET03535 | DBMET01742 | |
| 0.109 | 0.045 | 0.121 | Glutamate (mGluR7) agonist | 0.121 0.03 DBMET01742 0.09 0.084 DBMET03534 | DBMET01742 | |
| 0.086 | 0.023 | 0.086 | Cannabinoid CB2 receptor agonist | |||
| 0.146 | 0.084 | 0.207 | Anticoagulant | 0.132 0.098 DBMET03532 0.124 0.107 DBMET03533 0.207 0.05 DBMET01742 0.177 0.063 DBMET03534 0.147 0.083 DBMET03535 | DBMET01742 | |
| 0.122 | 0.06 | 0.122 | Calcium channel N-type blocker | 0.101 0.094 DBMET01742 | ||
| 0.218 | 0.156 | 0.248 | Antithrombotic | 0.246 0.129 DBMET03532 0.248 0.128 DBMET03533 0.243 0.132 DBMET00269 0.21 0.165 DBMET03534 0.207 0.169 DBMET03535 | DBMET03533 | |
| 0.074 | 0.013 | 0.074 | Prolyl endopeptidase inhibitor | 0.059 0.025 DBMET03532 0.053 0.032 DBMET03533 0.045 0.044 DBMET00269 0.065 0.019 DBMET01742 0.05 0.036 DBMET03534 | ||
| 0.176 | 0.117 | 0.204 | 5 Hydroxytryptamine 3E antagonist | 0.204 0.055 DBMET01742 | DBMET01742 | |
| 0.083 | 0.027 | 0.083 | Cannabinoid CB1 receptor agonist | |||
| 0.06 | 0.005 | 0.06 | Baculoviral IAP repeat-containing protein inhibitor | 0.055 0.01 DBMET03532 0.053 0.014 DBMET03533 0.053 0.014 DBMET00269 0.058 0.007 DBMET01742 0.053 0.015 DBMET03534 0.05 0.02 DBMET03535 | ||
| 0.224 | 0.169 | 0.237 | Calpain 2 inhibitor | 0.237 0.158 DBMET01742 | DBMET01742 | |
| 0.07 | 0.015 | 0.07 | Nicotinic receptor alpha3 subunit antagonist | 0.057 0.021 DBMET03532 0.043 0.031 DBMET03533 0.068 0.016 DBMET01742 0.055 0.022 DBMET03534 | ||
| 0.062 | 0.009 | 0.062 | Acetyl-CoA transferase 1 inhibitor | 0.052 0.015 DBMET03532 0.054 0.013 DBMET03533 0.05 0.017 DBMET00269 0.06 0.009 DBMET01742 0.049 0.019 DBMET03534 0.046 0.022 DBMET03535 | ||
| 0.208 | 0.155 | 0.218 | Thyroid hormone antagonist | 0.218 0.147 DBMET03532 0.213 0.15 DBMET00269 | DBMET03532 | |
| 0.125 | 0.073 | 0.194 | Toll-Like receptor 2 antagonist | 0.188 0.029 DBMET03532 0.146 0.055 DBMET03533 0.137 0.062 DBMET00269 0.132 0.066 DBMET01742 0.194 0.026 DBMET03534 0.145 0.056 DBMET03535 | DBMET03534 | |
| 0.213 | 0.162 | 0.244 | Vasodilator, peripheral | 0.238 0.137 DBMET03532 0.244 0.131 DBMET03533 | DBMET03533 | |
| 0.085 | 0.034 | 0.104 | Dopamine agonist | 0.104 0.026 DBMET03532 0.09 0.032 DBMET00269 | DBMET03532 | |
| 0.262 | 0.212 | 0.294 | 5 Hydroxytryptamine release inhibitor | 0.268 0.204 DBMET03532 0.288 0.179 DBMET01742 0.294 0.171 DBMET03534 | DBMET03534 | |
| 0.073 | 0.024 | 0.1 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.1 0.01 DBMET03532 0.076 0.022 DBMET00269 0.064 0.036 DBMET01742 0.085 0.016 DBMET03534 0.066 0.033 DBMET03535 | DBMET03532 | |
| 0.053 | 0.004 | 0.053 | Adenosine uptake inhibitor | 0.045 0.007 DBMET03532 0.038 0.015 DBMET03533 0.037 0.018 DBMET00269 0.033 0.031 DBMET01742 | ||
| 0.214 | 0.166 | 0.317 | Interleukin 2 agonist | 0.262 0.106 DBMET03532 0.317 0.062 DBMET03533 0.257 0.111 DBMET00269 0.227 0.147 DBMET01742 0.279 0.09 DBMET03534 0.273 0.095 DBMET03535 | DBMET03533 | |
| 0.081 | 0.035 | 0.107 | Neuronal nicotinic receptor antagonist | 0.067 0.048 DBMET03532 0.107 0.022 DBMET01742 0.09 0.029 DBMET03534 0.059 0.056 DBMET03535 | DBMET01742 | |
| 0.095 | 0.051 | 0.133 | Opioid antagonist | 0.133 0.031 DBMET03532 0.085 0.063 DBMET03533 0.104 0.045 DBMET00269 0.108 0.042 DBMET03534 0.082 0.066 DBMET03535 | DBMET03532 | |
| 0.052 | 0.009 | 0.052 | Peptide deformylase inhibitor | 0.036 0.017 DBMET03532 0.029 0.022 DBMET03533 0.027 0.026 DBMET00269 | ||
| 0.162 | 0.123 | 0.162 | Potassium channel blocker | |||
| 0.058 | 0.02 | 0.063 | Dopamine D5 antagonist | 0.063 0.018 DBMET03532 0.051 0.025 DBMET00269 | DBMET03532 | |
| 0.063 | 0.027 | 0.063 | 5 Hydroxytryptamine 7 agonist | 0.057 0.036 DBMET03532 0.051 0.05 DBMET00269 | ||
| 0.066 | 0.03 | 0.066 | Sphingosine 1-phosphate receptor 3 antagonist | 0.061 0.037 DBMET03532 0.058 0.04 DBMET03533 0.059 0.039 DBMET01742 0.054 0.049 DBMET03534 | ||
| 0.057 | 0.021 | 0.057 | CC chemokine 3 receptor antagonist | 0.037 0.033 DBMET03533 | ||
| 0.131 | 0.096 | 0.148 | Insulin secretagoues | 0.148 0.077 DBMET03532 0.119 0.113 DBMET03533 | DBMET03532 | |
| 0.072 | 0.037 | 0.072 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.066 | 0.031 | 0.066 | Calcium channel T-type blocker | |||
| 0.078 | 0.044 | 0.078 | Aminopeptidase I inhibitor | 0.072 0.051 DBMET03532 0.07 0.053 DBMET01742 0.065 0.061 DBMET03534 | ||
| 0.075 | 0.042 | 0.077 | Orexin receptor 1 antagonist | 0.077 0.039 DBMET01742 | DBMET01742 | |
| 0.046 | 0.015 | 0.046 | Glucose-6-phosphate dehydrogenase inhibitor | 0.046 0.015 DBMET03532 0.04 0.022 DBMET03533 0.042 0.018 DBMET00269 0.037 0.027 DBMET01742 0.038 0.025 DBMET03534 0.035 0.033 DBMET03535 | ||
| 0.078 | 0.048 | 0.078 | Acetylcholine M4 receptor antagonist | |||
| 0.054 | 0.027 | 0.055 | HCV NS3/NS4A protease inhibitor | 0.055 0.026 DBMET01742 | DBMET01742 | |
| 0.064 | 0.037 | 0.104 | Bombesin 1 receptor agonist | 0.055 0.047 DBMET03532 0.104 0.016 DBMET01742 0.086 0.023 DBMET03534 0.08 0.025 DBMET03535 | DBMET01742 | |
| 0.133 | 0.106 | 0.133 | Ca2+-transporting ATPase inhibitor | 0.131 0.114 DBMET03532 | ||
| 0.073 | 0.047 | 0.073 | Phospholipase D inhibitor | |||
| 0.056 | 0.03 | 0.056 | Chemokine receptor agonist | |||
| 0.066 | 0.04 | 0.066 | Acetylcholine M2 receptor antagonist | |||
| 0.068 | 0.043 | 0.069 | Orexin receptor antagonist | 0.069 0.041 DBMET01742 | DBMET01742 | |
| 0.038 | 0.013 | 0.038 | Epoxide hydrolase 1 inhibitor | 0.031 0.02 DBMET01742 | ||
| 0.036 | 0.012 | 0.053 | Prostaglandin EP4 antagonist | 0.028 0.016 DBMET03532 0.053 0.008 DBMET03533 0.024 0.02 DBMET00269 | DBMET03533 | |
| 0.191 | 0.17 | 0.285 | 5 Hydroxytryptamine uptake stimulant | 0.197 0.157 DBMET00269 0.275 0.06 DBMET01742 0.261 0.071 DBMET03534 0.285 0.053 DBMET03535 | DBMET03535 | |
| 0.033 | 0.012 | 0.033 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.031 0.014 DBMET03532 0.027 0.02 DBMET03533 0.028 0.018 DBMET00269 0.028 0.018 DBMET01742 0.026 0.022 DBMET03534 | ||
| 0.084 | 0.063 | 0.145 | Hematopoietic | 0.082 0.066 DBMET03532 0.083 0.064 DBMET03533 0.083 0.064 DBMET00269 0.145 0.016 DBMET01742 0.126 0.02 DBMET03534 0.125 0.02 DBMET03535 | DBMET01742 | |
| 0.044 | 0.023 | 0.044 | Dopamine D3 agonist | 0.042 0.025 DBMET03532 0.037 0.03 DBMET00269 | ||
| 0.026 | 0.005 | 0.026 | Baculoviral IAP repeat-containing protein 3 inhibitor | 0.022 0.012 DBMET03532 0.021 0.012 DBMET03533 0.021 0.014 DBMET00269 0.025 0.005 DBMET01742 0.021 0.014 DBMET03534 0.02 0.017 DBMET03535 | ||
| 0.06 | 0.041 | 0.06 | Acetylcholine M5 receptor antagonist | |||
| 0.072 | 0.053 | 0.072 | Thrombin inhibitor | |||
| 0.109 | 0.091 | 0.109 | Cathepsin H inhibitor | |||
| 0.054 | 0.037 | 0.065 | Nicotinic receptor alpha7 subunit antagonist | 0.065 0.024 DBMET01742 0.049 0.048 DBMET03534 | DBMET01742 | |
| 0.088 | 0.071 | 0.096 | Potassium channel (Voltage-sensitive) activator | 0.096 0.059 DBMET01742 | DBMET01742 | |
| 0.061 | 0.045 | 0.088 | Histone deacetylase SIRT3 inhibitor | 0.06 0.05 DBMET03532 0.088 0.014 DBMET01742 0.085 0.015 DBMET03534 0.069 0.03 DBMET03535 | DBMET01742 | |
| 0.055 | 0.039 | 0.076 | Glucosylceramidase inhibitor | 0.076 0.018 DBMET03533 0.05 0.049 DBMET01742 | DBMET03533 | |
| 0.065 | 0.05 | 0.105 | Opioid mu receptor antagonist | 0.105 0.03 DBMET03532 0.076 0.042 DBMET00269 0.077 0.041 DBMET03534 | DBMET03532 | |
| 0.024 | 0.01 | 0.024 | Apolipoprotein B inhibitor | |||
| 0.077 | 0.063 | 0.1 | Opioid kappa receptor antagonist | 0.1 0.035 DBMET03532 0.079 0.059 DBMET00269 0.083 0.054 DBMET03534 | DBMET03532 | |
| 0.075 | 0.062 | 0.075 | Viral attachment inhibitor | |||
| 0.043 | 0.031 | 0.043 | Histamine H3 receptor antagonist | |||
| 0.041 | 0.029 | 0.055 | Histone deacetylase 8 inhibitor | 0.055 0.019 DBMET01742 0.04 0.03 DBMET03534 | DBMET01742 | |
| 0.079 | 0.067 | 0.125 | Acetylcholine agonist | 0.125 0.035 DBMET01742 | DBMET01742 | |
| 0.02 | 0.009 | 0.025 | Complement factor D inhibitor | 0.025 0.005 DBMET01742 | DBMET01742 | |
| 0.025 | 0.014 | 0.025 | 5 Hydroxytryptamine 4 agonist | |||
| 0.094 | 0.083 | 0.108 | 5 Hydroxytryptamine 3A agonist | 0.108 0.067 DBMET01742 0.093 0.084 DBMET03534 | DBMET01742 | |
| 0.083 | 0.073 | 0.083 | Antihistaminic | |||
| 0.111 | 0.101 | 0.119 | Toll-Like receptor antagonist | 0.119 0.085 DBMET01742 0.115 0.093 DBMET03534 | DBMET01742 | |
| 0.073 | 0.063 | 0.073 | Cell adhesion molecule inhibitor | 0.07 0.069 DBMET01742 | ||
| 0.084 | 0.074 | 0.096 | Polo-like kinase-1 inhibitor | 0.096 0.051 DBMET01742 0.086 0.069 DBMET03534 | DBMET01742 | |
| 0.037 | 0.027 | 0.037 | Delayed rectifier potassium channel blocker | |||
| 0.066 | 0.057 | 0.074 | Protein kinase C beta inhibitor | 0.074 0.04 DBMET03532 0.063 0.062 DBMET01742 0.072 0.044 DBMET03534 | DBMET03532 | |
| 0.03 | 0.021 | 0.03 | Potassium channel subfamily K member 3 blocker | |||
| 0.024 | 0.015 | 0.024 | Aminopeptidase P inhibitor | |||
| 0.097 | 0.089 | 0.097 | Calcium channel (voltage-sensitive) blocker | |||
| 0.109 | 0.101 | 0.109 | Calcium channel blocker | |||
| 0.047 | 0.039 | 0.048 | Potassium channel (Inward rectifier) blocker | 0.048 0.037 DBMET03533 | DBMET03533 | |
| 0.046 | 0.04 | 0.047 | Cytokine production stimulant | 0.047 0.037 DBMET03533 | DBMET03533 | |
| 0.011 | 0.005 | 0.011 | Baculoviral IAP repeat-containing protein 2 inhibitor | 0.009 0.008 DBMET03532 0.01 0.005 DBMET01742 | ||
| 0.049 | 0.043 | 0.075 | Dipeptidyl peptidase inhibitor | 0.075 0.016 DBMET01742 | DBMET01742 | |
| 0.046 | 0.041 | 0.046 | Dopamine D4 agonist | |||
| 0.018 | 0.013 | 0.018 | Apolipoprotein B-100 inhibitor | |||
| 0.098 | 0.093 | 0.107 | Cell adhesion inhibitor | 0.107 0.077 DBMET03533 | DBMET03533 | |
| 0.027 | 0.023 | 0.028 | HCV NS5A inhibitor | 0.028 0.02 DBMET01742 | DBMET01742 | |
| 0.058 | 0.054 | 0.058 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.057 | 0.054 | 0.057 | Caspase 9 inhibitor | |||
| 0.042 | 0.039 | 0.042 | Sigma receptor antagonist | |||
| 0.052 | 0.048 | 0.056 | Cathepsin L inhibitor | 0.056 0.042 DBMET01742 | DBMET01742 | |
| 0.047 | 0.044 | 0.047 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.05 | 0.048 | 0.07 | Plasminogen activator inhibitor | 0.07 0.032 DBMET01742 0.064 0.036 DBMET03534 0.066 0.035 DBMET03535 | DBMET01742 | |
| 0.053 | 0.051 | 0.1 | Opioid delta receptor antagonist | 0.1 0.03 DBMET03532 0.061 0.046 DBMET00269 0.077 0.037 DBMET03534 | DBMET03532 | |
| 0.037 | 0.035 | 0.055 | Oxytocin agonist | 0.047 0.026 DBMET03532 0.038 0.034 DBMET00269 0.046 0.027 DBMET01742 0.055 0.02 DBMET03534 0.046 0.026 DBMET03535 | DBMET03534 | |
| 0.068 | 0.065 | 0.088 | Analgesic, opioid | 0.088 0.039 DBMET03532 0.084 0.043 DBMET03534 | DBMET03532 | |
| 0.07 | 0.07 | 0.086 | Interferon agonist | 0.086 0.043 DBMET03533 | DBMET03533 | |
| 0.04 | 0.039 | 0.183 | Dihydroorotase inhibitor | 0.183 0.003 DBMET01742 0.139 0.004 DBMET03534 0.119 0.005 DBMET03535 | DBMET01742 | |
| 0.027 | 0.027 | 0.027 | Caspase 2 inhibitor | 0.027 0.026 DBMET01742 | DBMET01742 | |
| 0.041 | 0.041 | 0.051 | Dipeptidyl peptidase IV inhibitor | 0.051 0.019 DBMET01742 | DBMET01742 | |
| 0.129 | 0.129 | 0.136 | Heat shock protein 70 antagonist | 0.136 0.092 DBMET03532 0.131 0.115 DBMET00269 0.136 0.093 DBMET03534 0.131 0.116 DBMET03535 | DBMET03534 | |
| 0.058 | 0.059 | 0.069 | Interferon inducer | 0.069 0.036 DBMET03533 | DBMET03533 | |
| 0.202 | 0.205 | 0.272 | GABA C receptor rho-3 antagonist | 0.223 0.181 DBMET03532 0.247 0.156 DBMET01742 0.272 0.136 DBMET03534 | DBMET03534 | |
| 0.031 | 0.035 | 0.04 | Nicotinic receptor beta4 subunit antagonist | 0.04 0.023 DBMET01742 0.04 0.023 DBMET03534 | DBMET03534 | |
| 0.031 | 0.035 | 0.041 | Ceramide glucosyltransferase inhibitor | 0.041 0.015 DBMET03533 | DBMET03533 | |
| 0.061 | 0.067 | 0.064 | Cathepsin G inhibitor | 0.064 0.062 DBMET03533 | DBMET03533 | |
| 0.083 | 0.089 | 0.112 | Electrolyte absorption antagonist | 0.112 0.043 DBMET01742 0.093 0.069 DBMET03535 | DBMET01742 | |
| 0.067 | 0.073 | 0.073 | Vanilloid 4 agonist | 0.073 0.057 DBMET01742 | DBMET01742 | |
| 0.084 | 0.091 | 0.101 | Ferrochelatase inhibitor | 0.101 0.07 DBMET01742 | DBMET01742 | |
| 0.051 | 0.059 | 0.117 | NMDA 2C receptor antagonist | 0.06 0.044 DBMET03532 0.1 0.016 DBMET01742 0.117 0.011 DBMET03534 0.079 0.026 DBMET03535 | DBMET03534 | |
| 0.031 | 0.039 | 0.036 | Cathepsin L1 inhibitor | 0.036 0.031 DBMET01742 | DBMET01742 | |
| 0.048 | 0.058 | 0.056 | Acetylcholine M3 receptor antagonist | 0.056 0.047 DBMET03532 | DBMET03532 | |
| 0.015 | 0.027 | 0.025 | Imidazoline I1 receptor antagonist | 0.025 0.01 DBMET01742 | DBMET01742 | |
| 0.023 | 0.035 | 0.028 | Complement C5a chemotactic receptor antagonist | 0.028 0.023 DBMET03533 | DBMET03533 | |
| 0.075 | 0.089 | 0.084 | T cell inhibitor | 0.084 0.054 DBMET01742 | DBMET01742 | |
| 0.03 | 0.046 | 0.044 | Dopamine D2 agonist | 0.044 0.031 DBMET03532 0.042 0.033 DBMET00269 | DBMET03532 | |
| 0.019 | 0.035 | 0.026 | Glutamate (mGluR1) agonist | 0.026 0.015 DBMET01742 0.025 0.017 DBMET03534 | DBMET01742 | |
| 0.084 | 0.101 | 0.153 | Hedgehog signaling inhibitor | 0.153 0.023 DBMET01742 0.118 0.041 DBMET03534 0.092 0.08 DBMET03535 | DBMET01742 | |
| 0.045 | 0.065 | 0.054 | Carbonic anhydrase stimulant | 0.054 0.048 DBMET01742 | DBMET01742 | |
| 0.141 | 0.163 | 0.223 | Immunostimulant | 0.201 0.12 DBMET03532 0.192 0.125 DBMET03533 0.162 0.145 DBMET01742 0.223 0.108 DBMET03534 0.172 0.138 DBMET03535 | DBMET03534 | |
| 0.025 | 0.047 | 0.035 | Melanocortin 1 antagonist | 0.035 0.029 DBMET01742 | DBMET01742 | |
| 0.042 | 0.064 | 0.055 | Alpha-mannosidase inhibitor | 0.052 0.039 DBMET03533 0.055 0.035 DBMET01742 0.055 0.034 DBMET03534 0.051 0.042 DBMET03535 | DBMET03534 | |
| 0.014 | 0.037 | 0.022 | Glutamate (mGluR1a) agonist | 0.022 0.016 DBMET01742 | DBMET01742 | |
| 0.19 | 0.214 | 0.236 | Histamine release inhibitor | 0.236 0.167 DBMET03532 | DBMET03532 | |
| 0.061 | 0.085 | 0.128 | Acetylcholine nicotinic agonist | 0.128 0.024 DBMET01742 0.085 0.05 DBMET03534 | DBMET01742 | |
| 0.024 | 0.049 | 0.035 | Dipeptidyl peptidase II inhibitor | 0.035 0.019 DBMET01742 | DBMET01742 | |
| 0.019 | 0.045 | 0.046 | Endothelial nitric-oxide synthase inhibitor | 0.046 0.01 DBMET01742 | DBMET01742 | |
| 0.019 | 0.046 | 0.044 | Gonadotropin-releasing hormone receptor antagonist | 0.044 0.019 DBMET01742 0.029 0.028 DBMET03534 | DBMET01742 | |
| 0.111 | 0.14 | 0.154 | Thiol protease inhibitor | 0.154 0.065 DBMET01742 0.123 0.11 DBMET03534 | DBMET01742 | |
| 0.015 | 0.044 | 0.025 | Melanocortin 5 antagonist | 0.025 0.019 DBMET01742 | DBMET01742 | |
| 0.083 | 0.113 | 0.1 | Proteasome inhibitor | 0.096 0.093 DBMET01742 0.1 0.087 DBMET03535 | DBMET03535 | |
| 0.039 | 0.069 | 0.067 | Nicotinic receptor alpha4 subunit antagonist | 0.067 0.018 DBMET01742 0.055 0.025 DBMET03534 0.047 0.038 DBMET03535 | DBMET01742 | |
| 0.077 | 0.109 | 0.095 | Bile acid receptor antagonist | 0.095 0.062 DBMET03532 0.09 0.073 DBMET00269 0.091 0.071 DBMET03534 0.086 0.084 DBMET03535 | DBMET03532 | |
| 0.031 | 0.064 | 0.051 | Opioid mu receptor agonist | 0.046 0.032 DBMET03532 0.051 0.028 DBMET03534 | DBMET03534 | |
| 0.031 | 0.064 | 0.061 | Melanocortin antagonist | 0.061 0.02 DBMET01742 0.048 0.032 DBMET03534 0.044 0.037 DBMET03535 | DBMET01742 | |
| 0.048 | 0.083 | 0.075 | Corticotropin releasing factor 2 receptor antagonist | 0.075 0.022 DBMET01742 | DBMET01742 | |
| 0.103 | 0.139 | 0.127 | Papain-like protease (SARS coronavirus) inhibitor | 0.115 0.094 DBMET03532 0.124 0.071 DBMET00269 0.117 0.09 DBMET03534 0.127 0.066 DBMET03535 | DBMET03535 | |
| 0.004 | 0.041 | 0.012 | Melatonin 5 antagonist | 0.012 0.007 DBMET01742 | DBMET01742 | |
| 0.094 | 0.133 | 0.183 | Histone deacetylase SIRT1 inhibitor | 0.111 0.103 DBMET03532 0.177 0.041 DBMET01742 0.183 0.038 DBMET03534 0.17 0.046 DBMET03535 | DBMET03534 | |
| 0.05 | 0.094 | 0.06 | Heme oxygenase stimulant | 0.06 0.046 DBMET03534 0.058 0.051 DBMET03535 | DBMET03534 | |
| 0.022 | 0.066 | 0.062 | Melanocortin 4 antagonist | 0.062 0.018 DBMET01742 0.044 0.028 DBMET03534 0.04 0.031 DBMET03535 | DBMET01742 | |
| 0.028 | 0.074 | 0.049 | Opioid agonist | 0.049 0.041 DBMET03532 0.049 0.041 DBMET03534 | DBMET03534 | |
| 0.043 | 0.088 | 0.053 | Cathepsin E inhibitor | 0.053 0.052 DBMET01742 | DBMET01742 | |
| 0.037 | 0.083 | 0.122 | CXC chemokine 4 receptor antagonist | 0.122 0.02 DBMET01742 0.092 0.027 DBMET03534 0.066 0.038 DBMET03535 | DBMET01742 | |
| 0.142 | 0.188 | 0.152 | MAP kinase kinase 5 inhibitor | 0.152 0.143 DBMET01742 | DBMET01742 | |
| 0.033 | 0.079 | 0.078 | Nicotinic neuronal receptor agonist | 0.078 0.023 DBMET01742 | DBMET01742 | |
| 0.123 | 0.17 | 0.159 | Hypolipemic | 0.159 0.128 DBMET03533 | DBMET03533 | |
| 0.066 | 0.114 | 0.11 | Creatine kinase inhibitor | 0.11 0.049 DBMET03532 0.087 0.076 DBMET00269 | DBMET03532 | |
| 0.023 | 0.072 | 0.049 | Dopamine D5 agonist | 0.043 0.024 DBMET03532 0.049 0.018 DBMET03534 | DBMET03534 | |
| 0.064 | 0.114 | 0.103 | MAP kinase kinase 7 inhibitor | 0.078 0.052 DBMET03532 0.088 0.028 DBMET01742 0.103 0.01 DBMET03534 0.094 0.019 DBMET03535 | DBMET03534 | |
| 0.104 | 0.155 | 0.208 | Hemostatic | 0.191 0.036 DBMET01742 0.208 0.029 DBMET03534 0.141 0.08 DBMET03535 | DBMET03534 | |
| 0.113 | 0.165 | 0.139 | CF transmembrane conductance regulator agonist | 0.139 0.098 DBMET03532 0.129 0.121 DBMET00269 0.134 0.109 DBMET03534 | DBMET03532 | |
| 0.037 | 0.089 | 0.069 | Androgen agonist | 0.055 0.048 DBMET01742 0.069 0.031 DBMET03534 0.055 0.048 DBMET03535 | DBMET03534 | |
| 0.045 | 0.098 | 0.062 | Gonadotropin-releasing hormone receptor agonist | 0.062 0.035 DBMET01742 0.062 0.036 DBMET03534 0.055 0.05 DBMET03535 | DBMET03534 | |
| 0.182 | 0.235 | 0.296 | Alpha-glucosidase inhibitor | 0.296 0.162 DBMET03532 0.228 0.2 DBMET03533 0.215 0.21 DBMET00269 0.226 0.202 DBMET03534 | DBMET03532 | |
| 0.052 | 0.108 | 0.077 | GABA aminotransferase inhibitor | 0.077 0.051 DBMET03534 | DBMET03534 | |
| 0.03 | 0.087 | 0.041 | DNA gyrase subunit A inhibitor | 0.041 0.034 DBMET03535 | DBMET03535 | |
| 0.068 | 0.128 | 0.139 | Nitric-oxide synthase inhibitor | 0.139 0.028 DBMET01742 0.105 0.052 DBMET03534 0.088 0.081 DBMET03535 | DBMET01742 | |
| 0.007 | 0.067 | 0.017 | Somatostatin 2 agonist | 0.017 0.008 DBMET01742 0.017 0.008 DBMET03534 | DBMET03534 | |
| 0.012 | 0.073 | 0.019 | Somatostatin 3 agonist | 0.019 0.012 DBMET01742 | DBMET01742 | |
| 0.147 | 0.209 | 0.24 | DNA synthesis inhibitor | 0.177 0.158 DBMET03532 0.199 0.124 DBMET03533 0.191 0.138 DBMET00269 0.204 0.116 DBMET01742 0.228 0.085 DBMET03534 0.24 0.074 DBMET03535 | DBMET03535 | |
| 0.079 | 0.141 | 0.131 | Alpha-N-acetylglucosaminidase inhibitor | 0.102 0.099 DBMET03533 0.131 0.068 DBMET01742 0.116 0.082 DBMET03534 0.101 0.1 DBMET03535 | DBMET01742 | |
| 0.077 | 0.139 | 0.139 | Lck kinase inhibitor | 0.139 0.072 DBMET01742 0.108 0.095 DBMET03534 | DBMET01742 | |
| 0.106 | 0.175 | 0.133 | Interferon gamma antagonist | 0.133 0.106 DBMET03532 0.132 0.107 DBMET03534 | DBMET03532 | |
| 0.06 | 0.131 | 0.079 | Factor XII inhibitor | 0.079 0.068 DBMET01742 | DBMET01742 | |
| 0.028 | 0.1 | 0.05 | CC chemokine 4 receptor antagonist | 0.05 0.028 DBMET01742 | DBMET01742 | |
| 0.011 | 0.085 | 0.063 | Dipeptidyl peptidase I inhibitor | 0.063 0.006 DBMET01742 0.034 0.017 DBMET03534 0.031 0.02 DBMET03535 | DBMET01742 | |
| 0.017 | 0.092 | 0.035 | Motilin receptor antagonist | 0.026 0.022 DBMET01742 0.025 0.024 DBMET03534 0.035 0.01 DBMET03535 | DBMET03535 | |
| 0.021 | 0.098 | 0.038 | Membrane dipeptidase inhibitor | 0.038 0.029 DBMET01742 | DBMET01742 | |
| 0.025 | 0.102 | 0.065 | Phenylethanolamine N methyltransferase inhibitor | 0.065 0.006 DBMET01742 0.058 0.008 DBMET03534 0.054 0.011 DBMET03535 | DBMET01742 | |
| 0.022 | 0.101 | 0.033 | ADAM10 endopeptidase inhibitor | 0.033 0.024 DBMET01742 | DBMET01742 | |
| 0.076 | 0.158 | 0.167 | Lipid peroxidase inhibitor | 0.167 0.057 DBMET03532 0.14 0.075 DBMET00269 0.155 0.065 DBMET03534 0.125 0.089 DBMET03535 | DBMET03532 | |
| 0.141 | 0.223 | 0.18 | Peptidyltransferase inhibitor | 0.18 0.128 DBMET03532 | DBMET03532 | |
| 0.055 | 0.138 | 0.095 | Potassium channel activator | 0.095 0.053 DBMET01742 0.081 0.074 DBMET03535 | DBMET01742 | |
| 0.077 | 0.162 | 0.219 | Thrombolytic | 0.213 0.046 DBMET01742 0.219 0.044 DBMET03534 0.198 0.053 DBMET03535 | DBMET03534 | |
| 0.005 | 0.093 | 0.028 | Melatonin 3 antagonist | 0.028 0.009 DBMET01742 | DBMET01742 | |
| 0.009 | 0.097 | 0.036 | Nicotinic alpha4beta2 receptor agonist | 0.036 0.011 DBMET01742 0.03 0.018 DBMET03534 | DBMET01742 | |
| 0.114 | 0.205 | 0.167 | Neurotrophic factor enhancer | 0.167 0.114 DBMET03532 0.149 0.139 DBMET03533 | DBMET03532 | |
| 0.081 | 0.174 | 0.157 | Protein kinase stimulant | 0.109 0.106 DBMET03532 0.157 0.064 DBMET03533 0.135 0.079 DBMET03534 | DBMET03533 | |
| 0.025 | 0.119 | 0.055 | Maillard reaction inhibitor | 0.055 0.038 DBMET03535 | DBMET03535 | |
| 0.005 | 0.102 | 0.035 | Growth hormone secretagogue receptor agonist | 0.035 0.024 DBMET01742 | DBMET01742 | |
| 0.006 | 0.104 | 0.016 | Nicotinic alpha4 receptor agonist | 0.016 0.011 DBMET01742 | DBMET01742 | |
| 0.036 | 0.136 | 0.065 | Polo-like kinase-2 inhibitor | 0.065 0.058 DBMET01742 | DBMET01742 | |
| 0.05 | 0.149 | 0.151 | Inducible nitric-oxide synthase inhibitor | 0.151 0.016 DBMET01742 0.124 0.023 DBMET03534 0.098 0.039 DBMET03535 | DBMET01742 | |
| 0.013 | 0.113 | 0.036 | Somatostatin agonist | 0.036 0.019 DBMET01742 0.03 0.023 DBMET03534 | DBMET01742 | |
| 0.109 | 0.209 | 0.141 | ATPase inhibitor | 0.141 0.117 DBMET03534 | DBMET03534 | |
| 0.026 | 0.128 | 0.069 | Cyclin A1 inhibitor | 0.069 0.024 DBMET01742 | DBMET01742 | |
| 0.014 | 0.116 | 0.059 | NMDA receptor subunit 3A antagonist | 0.059 0.017 DBMET03534 | DBMET03534 | |
| 0.095 | 0.198 | 0.162 | Adenylate cyclase stimulant | 0.128 0.107 DBMET03532 0.132 0.098 DBMET01742 0.162 0.045 DBMET03534 0.144 0.073 DBMET03535 | DBMET03534 | |
| 0.17 | 0.273 | 0.219 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.219 0.117 DBMET01742 | DBMET01742 | |
| 0.162 | 0.267 | 0.187 | MAP kinase kinase 3 inhibitor | 0.187 0.165 DBMET01742 | DBMET01742 | |
| 0.01 | 0.116 | 0.031 | Motilin receptor agonist | 0.031 0.009 DBMET01742 0.024 0.015 DBMET03534 0.021 0.018 DBMET03535 | DBMET01742 | |
| 0.135 | 0.245 | 0.261 | Transcription factor NF kappa B inhibitor | 0.243 0.132 DBMET03532 0.196 0.173 DBMET03533 0.194 0.175 DBMET00269 0.261 0.12 DBMET03534 0.211 0.158 DBMET03535 | DBMET03534 | |
| 0.051 | 0.162 | 0.075 | Estrogen receptor alpha antagonist | 0.075 0.057 DBMET03532 | DBMET03532 | |
| 0.019 | 0.131 | 0.059 | NMDA receptor subunit 3B antagonist | 0.059 0.02 DBMET03534 0.039 0.036 DBMET03535 | DBMET03534 | |
| 0.058 | 0.174 | 0.111 | Adenylate cyclase inhibitor | 0.111 0.075 DBMET03534 | DBMET03534 | |
| 0.017 | 0.147 | 0.04 | Integrin alpha2 antagonist | 0.04 0.02 DBMET01742 | DBMET01742 | |
| 0.008 | 0.141 | 0.032 | Nicotinic alpha3beta4 receptor agonist | 0.032 0.018 DBMET01742 | DBMET01742 | |
| 0.018 | 0.152 | 0.038 | Tryptophan 5 hydroxylase inhibitor | 0.038 0.019 DBMET01742 | DBMET01742 | |
| 0.109 | 0.246 | 0.153 | Catenin beta inhibitor | 0.147 0.114 DBMET03534 0.153 0.1 DBMET03535 | DBMET03535 | |
| 0.133 | 0.273 | 0.234 | Nitric-oxide synthase stimulant | 0.208 0.077 DBMET01742 0.234 0.045 DBMET03534 0.197 0.095 DBMET03535 | DBMET03534 | |
| 0.044 | 0.193 | 0.092 | Bronchodilator | 0.083 0.082 DBMET03533 0.092 0.073 DBMET00269 | DBMET00269 | |
| 0.17 | 0.321 | 0.329 | Apoptosis agonist | 0.271 0.194 DBMET03532 0.329 0.152 DBMET00269 0.246 0.219 DBMET03534 0.313 0.163 DBMET03535 | DBMET00269 | |
| 0.051 | 0.203 | 0.096 | GABA C receptor rho-1 antagonist | 0.096 0.068 DBMET01742 0.09 0.078 DBMET03534 | DBMET01742 | |
| 0.03 | 0.182 | 0.066 | I kappa B kinase 2 inhibitor | 0.066 0.037 DBMET01742 0.06 0.047 DBMET03534 | DBMET01742 | |
| 0.085 | 0.241 | 0.166 | Aldehyde oxidase inhibitor | 0.166 0.126 DBMET03532 | DBMET03532 | |
| 0.104 | 0.261 | 0.151 | Death-associated protein kinase 2 inhibitor | 0.151 0.103 DBMET03534 | DBMET03534 | |
| 0.072 | 0.237 | 0.125 | MAP3K9 inhibitor | 0.119 0.116 DBMET03533 0.125 0.103 DBMET01742 0.124 0.106 DBMET03534 | DBMET01742 | |
| 0.025 | 0.191 | 0.074 | Alpha 1L adrenoreceptor agonist | 0.056 0.011 DBMET00269 0.074 0.005 DBMET03535 | DBMET03535 | |
| 0.035 | 0.202 | 0.092 | Adrenaline agonist | 0.084 0.053 DBMET03534 0.092 0.044 DBMET03535 | DBMET03535 | |
| 0.097 | 0.266 | 0.138 | Phospholipase C inhibitor | 0.138 0.133 DBMET03534 | DBMET03534 | |
| 0.028 | 0.197 | 0.064 | NMDA receptor agonist | 0.064 0.042 DBMET01742 0.057 0.052 DBMET03534 | DBMET01742 | |
| 0.111 | 0.28 | 0.152 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.152 0.144 DBMET03534 | DBMET03534 | |
| 0.034 | 0.205 | 0.072 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.072 0.055 DBMET01742 | DBMET01742 | |
| 0.063 | 0.235 | 0.117 | Interleukin 4 antagonist | 0.117 0.09 DBMET03532 0.107 0.106 DBMET00269 | DBMET03532 | |
| 0.071 | 0.244 | 0.124 | Farnesoid X receptor antagonist | 0.124 0.095 DBMET03532 0.116 0.112 DBMET00269 0.116 0.112 DBMET03534 | DBMET03532 | |
| 0.043 | 0.217 | 0.135 | GABA C receptor agonist | 0.123 0.048 DBMET01742 0.135 0.041 DBMET03534 0.103 0.063 DBMET03535 | DBMET03534 | |
| 0.02 | 0.194 | 0.075 | 5 Hydroxytryptamine 2A agonist | 0.075 0.032 DBMET01742 0.075 0.032 DBMET03534 | DBMET03534 | |
| 0.057 | 0.238 | 0.126 | Estrogen antagonist | 0.126 0.044 DBMET03532 0.111 0.073 DBMET00269 0.116 0.062 DBMET03534 | DBMET03532 | |
| 0.08 | 0.261 | 0.137 | Melanin inhibitor | 0.137 0.101 DBMET03534 0.128 0.118 DBMET03535 | DBMET03534 | |
| 0.012 | 0.194 | 0.051 | 5 Hydroxytryptamine 2 agonist | 0.051 0.037 DBMET01742 | DBMET01742 | |
| 0.063 | 0.246 | 0.099 | Interleukin 8 antagonist | 0.099 0.098 DBMET03534 | DBMET03534 | |
| 0.132 | 0.319 | 0.192 | Apoptosis antagonist | 0.192 0.191 DBMET03532 | DBMET03532 | |
| 0.044 | 0.238 | 0.098 | GABA C receptor antagonist | 0.096 0.085 DBMET01742 0.098 0.081 DBMET03534 | DBMET03534 | |
| 0.072 | 0.27 | 0.124 | NOS3 expression enhancer | 0.124 0.107 DBMET03534 | DBMET03534 | |
| 0.074 | 0.275 | 0.124 | GABA C receptor rho-2 antagonist | 0.124 0.117 DBMET01742 | DBMET01742 | |
| 0.028 | 0.229 | 0.046 | Factor III inhibitor | 0.046 0.045 DBMET03534 | DBMET03534 | |
| 0.034 | 0.244 | 0.059 | Beta 2 adrenoreceptor agonist | 0.059 0.053 DBMET03535 | DBMET03535 | |
| 0.076 | 0.294 | 0.144 | Tumour necrosis factor antagonist | 0.144 0.109 DBMET01742 0.141 0.112 DBMET03534 | DBMET01742 | |
| 0.072 | 0.292 | 0.159 | Antiamyloidogenic | 0.159 0.136 DBMET03535 | DBMET03535 | |
| 0.041 | 0.276 | 0.143 | Amylase inhibitor | 0.143 0.068 DBMET03534 | DBMET03534 | |
| 0.027 | 0.271 | 0.076 | I kappa B kinase inhibitor | 0.076 0.067 DBMET01742 | DBMET01742 | |
| 0.014 | 0.262 | 0.036 | 5 Hydroxytryptamine 2B agonist | 0.036 0.033 DBMET01742 | DBMET01742 | |
| 0.038 | 0.288 | 0.11 | Estrogen receptor beta antagonist | 0.11 0.047 DBMET03532 0.094 0.076 DBMET00269 0.105 0.056 DBMET03534 | DBMET03532 | |
| 0.037 | 0.287 | 0.098 | Histone deacetylase class III inhibitor | 0.098 0.092 DBMET03534 | DBMET03534 | |
| 0.037 | 0.294 | 0.115 | Sodium channel (voltage-gated) blocker | 0.115 0.09 DBMET01742 | DBMET01742 | |
| 0.047 | 0.307 | 0.188 | Angiogenesis stimulant | 0.188 0.101 DBMET03534 0.149 0.123 DBMET03535 | DBMET03534 | |
| 0.101 | 0.365 | 0.206 | Antiobesity | 0.206 0.202 DBMET01742 | DBMET01742 | |
| 0.006 | 0.28 | 0.061 | 5 Hydroxytryptamine 2C agonist | 0.061 0.02 DBMET01742 0.039 0.038 DBMET03534 | DBMET01742 | |
| 0.047 | 0.343 | 0.124 | Peroxidase inhibitor | 0.124 0.096 DBMET03534 | DBMET03534 | |
| 0.022 | 0.322 | 0.081 | Pim-3 kinase inhibitor | 0.081 0.076 DBMET01742 | DBMET01742 | |
| 0.005 | 0.305 | 0.061 | Secretase gamma inhibitor | 0.061 0.018 DBMET03533 | DBMET03533 | |
| 0.027 | 0.342 | 0.098 | Cystathionine beta-synthase inhibitor | 0.098 0.079 DBMET03534 | DBMET03534 | |
| 0.051 | 0.373 | 0.138 | Platelet adhesion inhibitor | 0.138 0.12 DBMET03534 | DBMET03534 | |
| 0.092 | 0.417 | 0.208 | Sodium/bile acid cotransporter inhibitor | 0.208 0.177 DBMET03532 | DBMET03532 | |
| 0.036 | 0.396 | 0.119 | Cell wall synthesis inhibitor | 0.119 0.101 DBMET03534 | DBMET03534 | |
| 0.036 | 0.399 | 0.155 | Amyloid beta aggregation inhibitor | 0.155 0.104 DBMET03535 | DBMET03535 | |
| 0.043 | 0.412 | 0.216 | Free radical scavenger | 0.165 0.129 DBMET03532 0.216 0.085 DBMET03534 0.176 0.118 DBMET03535 | DBMET03534 | |
| 0.066 | 0.494 | 0.244 | Antibacterial | 0.244 0.183 DBMET03534 0.226 0.201 DBMET03535 | DBMET03534 | |
| 0.037 | 0.486 | 0.163 | Antioxidant | 0.163 0.15 DBMET03534 | DBMET03534 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |